Dr. Richard D. Hall Jr., MD

Dr. Hall practices at Emily Couric Clinical Cancer Center in Charlottesville, Virginia.

Dr. Hall's NPI, 1649474040, was assigned on June 12, 2007. Dr. Hall graduated from UT Southwestern Medical Center in 2007. Dr. Hall holds Virginia license 0101248486.

Dr. Hall's primary practice is Emily Couric Clinical Cancer Center, at 1240 Lee St,, Charlottesville, VA 22903. The practice phone is (434) 243-4704.

Dr. Hall's primary practice is Emily Couric Clinical Cancer Center in Charlottesville, Virginia. Dr. Hall is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Hall to 2 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Hall's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hall practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Hall's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Hall is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Hall's licenses on file in 2 states: Virginia and Florida.

Dmand AI lists fluid and electrolyte imbalances and lung cancer among the conditions Dr. Hall treats.

CMS data shows 818 Medicare services from Dr. Hall across 7 procedure codes in 2024, for 164 Medicare patients. Medicare paid $49,972 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 164 Medicare patients who saw Dr. Hall in 2024. The largest group is 75 to 84, with 74 patients. 75% of them have cancer, and 72% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hall's median patient age at 68, with 53% women.

In 2024, Dr. Hall wrote 738 Medicare Part D claims for 101 patients. 73% of them were for generic drugs. CMS names the drug for 526 of them, across 21 drugs with 11 or more claims each, at $1,041,998 in total drug cost. In 2023, CMS named 315 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Hall for performance year 2024, reported as part of a group. Dr. Hall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hall as offering telehealth.

Dmand AI links 24 papers to Dr. Hall, published from 2011 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Protein Kinase Inhibitors. Dr. Hall has published most often in Cancer Res. Dr. Hall's most frequent co-authors are Ryan D. Gentzler, MD, Camilo E. Fadul, MD and Jhanelle E. Gray, MD.

CMS Open Payments shows 76 general payments to Dr. Hall from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Merck Sharp & Dohme Corporation paid the most, $25,971.

Dr. Hall graduated from UT Southwestern Medical Center in 2007. Dr. Hall is a member of ASCO.

Dr. Hall is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.